What are the most common medical diagnoses encountered by an endocrinologist?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Diagnoses Encountered by Endocrinologists

Diabetes mellitus is the most commonly encountered endocrinopathy in clinical practice, followed by thyroid disorders (hypothyroidism, hyperthyroidism, and thyroid nodules), and polycystic ovary syndrome (PCOS) in women of reproductive age. 1, 2, 3, 4, 5

Primary Endocrine Diagnoses by Frequency

Diabetes Mellitus

  • Type 2 diabetes represents the single most prevalent endocrine disorder, with incidence doubling over the past decade and projected to continue increasing dramatically. 5
  • Type 1 diabetes, while less common than type 2, requires more intensive management and accounts for a significant proportion of endocrine consultations. 1, 5
  • Diabetes accounts for approximately 1.7% of all diagnoses in general medical practice, making it the most frequent endocrine dysfunction requiring treatment. 4

Thyroid Disorders

  • Thyroid disease collectively affects 5.8% of general practice patients, making the thyroid gland the most frequently affected endocrine organ. 4
  • Hypothyroidism occurs in approximately 0.53% of patients and presents with fatigue, weight gain, cold intolerance, and menstrual irregularities in women. 6, 3, 4
  • Hyperthyroidism affects approximately 0.38% of patients and manifests with weight loss, heat intolerance, palpitations, and tremor. 3, 4
  • Thyroid nodules require evaluation to exclude malignancy and assess functional status. 3
  • Post-thyroidectomy patients requiring thyroid hormone replacement represent 1.4% of endocrine diagnoses. 4

Polycystic Ovary Syndrome (PCOS)

  • PCOS is recognized as the most common endocrine disorder of reproductive-aged women worldwide, characterized by hyperandrogenism, ovulatory dysfunction, and insulin resistance. 2, 3
  • PCOS accounts for a substantial proportion of menstrual irregularities, with 45% of women on certain antiepileptic drugs (particularly valproate) developing PCOS-like features. 6
  • Women with PCOS have a 1.5-times higher baseline risk of venous thromboembolic disease. 2

Secondary Common Endocrine Diagnoses

Reproductive Endocrine Disorders in Women

  • Hyperprolactinemia accounts for approximately 20% of secondary amenorrhea cases and causes anovulation by suppressing kisspeptin and gonadotropin secretion. 6, 7, 8
  • Hypothalamic amenorrhea presents with disturbed gonadotropin secretion and low LH levels without hyperandrogenism. 6
  • Premature ovarian failure occurs in approximately 4% of women with certain neurological conditions, presenting with amenorrhea and FSH >50 mIU/L before age 40. 6

Adrenal Disorders

  • Cushing's syndrome results from excess cortisol and presents with characteristic physical findings including central obesity, moon facies, and purple striae. 1, 3
  • Adrenal insufficiency (both primary and secondary) requires glucocorticoid replacement, with tertiary adrenal insufficiency being far more common due to iatrogenic exogenous glucocorticoid therapy. 5
  • Primary adrenal insufficiency causes both glucocorticoid and mineralocorticoid deficiency. 5

Pituitary Disorders

  • Hypophysitis and other pituitary hormone deficiencies present with multiple hormonal deficits, most commonly affecting growth hormone, gonadotropins, and ACTH. 1
  • Central diabetes insipidus occurs in 25-50% of certain histiocytic disorders and may precede diagnosis by years. 1

Metabolic Complications and Screening Priorities

Diabetes-Related Screening

  • All women with PCOS require evaluation for metabolic syndrome components, including type 2 diabetes (7.5-10% prevalence), impaired glucose tolerance (31-35%), hypertension, and hyperlipidemia. 2
  • Rates of progression from normal glucose tolerance to impaired glucose tolerance, and subsequently to type 2 diabetes, may be as high as 5-15% within 3 years in PCOS patients. 2
  • Baseline oral glucose tolerance testing every 1-2 years is recommended based on family history and BMI, with yearly testing in women with impaired glucose tolerance. 2

Thyroid-Related Menstrual Dysfunction

  • Primary hypothyroidism causes menstrual irregularities in a substantial proportion of affected women, with hyperprolactinemia occurring in 43% of women with frank hypothyroidism and 36% with subclinical hypothyroidism. 6
  • Menstrual cycles typically normalize within 2-5 days of achieving adequate thyroid hormone replacement with levothyroxine. 6, 7

Critical Clinical Context

Drug-Induced Endocrinopathies

  • Antiepileptic drugs cause endocrine disorders through direct influence on hypothalamic-pituitary control centers, effects on peripheral endocrine glands, altered hormone metabolism, and secondary complications from weight changes or insulin sensitivity changes. 1
  • Immune checkpoint inhibitor therapy causes clinically significant endocrinopathies in approximately 10% of treated patients, with median time to onset of 14.5 weeks (range 1.5-130 weeks). 1

Prevalence in Clinical Practice

  • One out of every 25 diagnoses in general practice is an endocrinopathy, and every 35th practice patient has an endocrine disease requiring treatment. 4
  • Endocrine laboratory tests are ordered in approximately one out of every seven patients. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Endocrinopathies.

The Medical clinics of North America, 2022

Research

Assessment and therapy of selected endocrine disorders.

Anesthesiology clinics of North America, 2004

Guideline

Endocrine Disorders Causing Menstrual Irregularities

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Investigation for Amenorrhea in Women of Reproductive Age

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hormonal Evaluation in Secondary Amenorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the diagnostic and treatment approaches for common endocrinological disorders?
What are the next steps for a female patient of reproductive age with concerns for endometriosis and polycystic ovarian syndrome (PCOS) who had a transvaginal ultrasound showing normal endometrial thickness, non-visualization of the right ovary due to overlying bowel gas, and otherwise unremarkable pelvic sonography?
Are endocrine issues more common in pediatrics?
What is the best treatment for Polycystic Ovary Syndrome (PCOS)?
What are the next steps in managing a 22-year-old female with Polycystic Ovary Syndrome (PCOS), uncontrolled heavy menstrual bleeding despite Combined Oral Contraceptive Pills (COCP), and mildly elevated prolactin levels?
What do MRI results showing chronic microvascular ischemic changes, Dandy-Walker variant, colpocephaly, and straightening of the cervical lordotic curvature mean for a patient with a history of stroke or other vascular conditions?
What are the common side effects of an indwelling pleural catheter (IPC)?
What are the current treatment recommendations for a patient presenting with a calcaneal spur?
What is the staging process and treatment approach for a patient with invasive ductal carcinoma?
When are uricosuric drugs, such as probenecid, prescribed for patients with gout or hyperuricemia?
What study/trial shows benefit of early cardiac catheterization in out-of-hospital cardiac arrest (OHCA) survivors diagnosed with ST-elevation myocardial infarction (STEMI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.